National Tunisian Registry of Percutaneous Coronary Intervention
Launched by DACIMA CONSULTING · Jan 5, 2020
Trial Information
Current as of April 27, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Tunisian patient needing PCI (Percutaneous Coronary Intervention) at the enrollment period
- • Informed and signed consent
- Exclusion Criteria:
- • Withdrawn consent
About Dacima Consulting
Dacima Consulting is a leading clinical trial sponsor specializing in innovative solutions for the pharmaceutical and biotechnology industries. With a commitment to advancing healthcare, Dacima leverages cutting-edge technology and a team of experienced professionals to design, manage, and execute clinical trials efficiently and effectively. Their comprehensive services encompass protocol development, regulatory support, data management, and statistical analysis, ensuring high-quality results that facilitate the drug development process. Dacima Consulting is dedicated to enhancing patient outcomes through rigorous research, strategic collaboration, and a patient-centered approach.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tunis, , Tunisia
Patients applied
Trial Officials
Leila Abid, MD
Study Chair
Tunisian Society of Cardiology and Cardiovascular Surgery
Rania Hammami, MD
Principal Investigator
Tunisian Society of Cardiology and Cardiovascular Surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials